Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

Inclusion Criteria:

• Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment
• Naïve to botulinum toxin therapy of any serotype for any indication
• Naïve to prescription eyelash growth products of any type
• Naïve to dermal filler treatment in the face and neck

Exclusion Criteria:

• Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial dermal filler injections
• Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or chemical peel in the face or neck
• Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, chemical peel, or non-ablative procedures) in the face or neck within 3 months
• Systemic retinoid therapy within 1 year prior to study enrollment
• Presence of inflammation at the proposed injection site(s)
• Profound atrophy/excessive weakness of muscles in target areas of injection
• Known immunization or hypersensitivity to any botulinum toxin serotype
• Undergone oral surgery or dental procedures within 30 days
• No visible eyelashes
• Use of permanent eyeliner, eyelash implants, semi-permanent eyelash tint, dye or extension
• Use of prescription eyelash growth products
• Unwilling or unable to remove contact lenses prior to study medication application in the evening and keep lenses out for 30 minutes
• Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, amyotrophic lateral sclerosis, or any other disease that might interfere with neuromuscular function.